Tin tức & Cập nhật
Xem bài viết Ung thư
Xem
Chỉ hiển thị Multimedia

Is 5-year interval sufficient for prostate cancer screening in older men?
18 Aug 2022
bởiRoshini Claire Anthony
Diagnosis, progression, or death due to prostate cancer occur at approximately a decade to 15 years following an initial assessment of prostate-specific antigen (PSA) levels in older men, according to a study presented at EAU 2022.
18 Aug 2022

Local failure tied to survival in intermediate-risk PCa after definitive radiotherapy
18 Aug 2022
bởiTristan Manalac
In men with intermediate- or high-risk prostate cancer (PCa), local failure after definitive radiation therapy (RT) is indicative of survival outcomes, according to a recent study.
18 Aug 2022

Survival benefit with postchemoradiation immunotherapy affirmed
15 Aug 2022
bởiJairia Dela Cruz
Starting immunotherapy after chemotherapy and radiation for unresectable stage III nonsmall cell lung cancer (NSCLC) prolongs overall survival, regardless of patient age, health, and socioeconomic status, according to a large US study.
15 Aug 2022





